Literature DB >> 17548549

A randomized controlled trial of resistance exercise in individuals with ALS.

V Dal Bello-Haas1, J M Florence, A D Kloos, J Scheirbecker, G Lopate, S M Hayes, E P Pioro, H Mitsumoto.   

Abstract

OBJECTIVE: To determine the effects of resistance exercise on function, fatigue, and quality of life in individuals with ALS.
METHODS: Subjects with a diagnosis of clinically definite, probable, or laboratory-supported ALS, forced vital capacity (FVC) of 90% predicted or greater, and an ALS Functional Rating Scale (ALSFRS) score of 30 or greater were randomly assigned to a resistance exercise group that received a home exercise program consisting of daily stretching and resistance exercises three times weekly or to a usual care group, who performed only the daily stretching exercises. ALSFRS, the Fatigue Severity Scale (FSS), and Short Form-36 (SF-36) were completed at baseline and monthly for 6 months. FVC and maximum voluntary isometric contraction (MVIC) were monitored monthly throughout the study.
RESULTS: Of 33 subjects screened, 27 were randomly assigned (resistance = 13; usual care = 14). Eight resistance exercise subjects and 10 usual care subjects completed the trial. At 6 months, the resistance exercise group had significantly higher ALSFRS and SF-36 physical function subscale scores. No adverse events related to the intervention occurred, MVIC and FVC indicated no negative effects, and less decline in leg strength measured by MVIC was found in the resistance exercise group.
CONCLUSION: Our study, although small, showed that the resistance exercise group had significantly better function, as measured by total ALS Functional Rating Scale and upper and lower extremity subscale scores, and quality of life without adverse effects as compared with subjects receiving usual care.

Entities:  

Mesh:

Year:  2007        PMID: 17548549     DOI: 10.1212/01.wnl.0000264418.92308.a4

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  46 in total

Review 1.  Neuroprotection for amyotrophic lateral sclerosis: role of stem cells, growth factors, and gene therapy.

Authors:  Rachna S Pandya; Lilly L J Mao; Edward W Zhou; Robert Bowser; Zhenglun Zhu; Yongjin Zhu; Xin Wang
Journal:  Cent Nerv Syst Agents Med Chem       Date:  2012-03

Review 2.  ALS drug development: reflections from the past and a way forward.

Authors:  Swati Aggarwal; Merit Cudkowicz
Journal:  Neurotherapeutics       Date:  2008-10       Impact factor: 7.620

3.  Recumbent stepping aerobic exercise in amyotrophic lateral sclerosis: a pilot study.

Authors:  Anjali Sivaramakrishnan; Sangeetha Madhavan
Journal:  Neurol Sci       Date:  2019-02-04       Impact factor: 3.307

4.  Strictly monitored exercise programs reduce motor deterioration in ALS: preliminary results of a randomized controlled trial.

Authors:  Christian Lunetta; Andrea Lizio; Valeria A Sansone; Nadia Maria Cellotto; Eleonora Maestri; Massimo Bettinelli; Valentina Gatti; Mario Giovanni Melazzini; Giovanni Meola; Massimo Corbo
Journal:  J Neurol       Date:  2016-01       Impact factor: 4.849

5.  Amyotrophic lateral sclerosis, physical exercise, trauma and sports: results of a population-based pilot case-control study.

Authors:  Ettore Beghi; Giancarlo Logroscino; Adriano Chiò; Orla Hardiman; Andrea Millul; Douglas Mitchell; Robert Swingler; Bryan J Traynor
Journal:  Amyotroph Lateral Scler       Date:  2010-05-03

Review 6.  Effects of exercise on sleep in neurodegenerative disease.

Authors:  Adeel A Memon; Juliana J Coleman; Amy W Amara
Journal:  Neurobiol Dis       Date:  2020-04-01       Impact factor: 5.996

7.  Moderate exercise delays the motor performance decline in a transgenic model of ALS.

Authors:  Isabel Carreras; Sinan Yuruker; Nurgul Aytan; Lokman Hossain; Ji-Kyung Choi; Bruce G Jenkins; Neil W Kowall; Alpaslan Dedeoglu
Journal:  Brain Res       Date:  2009-12-05       Impact factor: 3.252

Review 8.  Physical activity and neuroprotection in amyotrophic lateral sclerosis.

Authors:  Mary E McCrate; Brian K Kaspar
Journal:  Neuromolecular Med       Date:  2008-02-20       Impact factor: 3.843

9.  Impact of expiratory strength training in amyotrophic lateral sclerosis.

Authors:  Emily K Plowman; Stephanie A Watts; Lauren Tabor; Raele Robison; Joy Gaziano; Amanda S Domer; Joel Richter; Tuan Vu; Clifton Gooch
Journal:  Muscle Nerve       Date:  2016-03-03       Impact factor: 3.217

10.  A conditioning lesion provides selective protection in a rat model of Amyotrophic Lateral Sclerosis.

Authors:  Colin K Franz; Eric T Quach; Christina A Krudy; Thais Federici; Michele A Kliem; Brooke R Snyder; Bethwel Raore; Nicholas M Boulis
Journal:  PLoS One       Date:  2009-10-06       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.